Veterinary Infectious Disease Diagnostics Market Report 2026

The veterinary infectious disease diagnostics market size has grown strongly in recent years. It will grow from $2.11 billion in 2025 to $2.31 billion in 2026 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to rising prevalence of viral and bacterial infections in animals, growth of companion animal population, expansion of veterinary hospitals and clinics, traditional reliance on laboratory testing, increasing awareness of zoonotic diseases.

The veterinary infectious disease diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.34 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to advancements in molecular and immunodiagnostic technologies, increasing adoption of point-of-care testing devices, rising investments in veterinary diagnostic infrastructure, growing demand for rapid infectious disease detection, expansion of research institutes and universities in veterinary health. Major trends in the forecast period include increasing adoption of molecular diagnostics, rising demand for point-of-care testing, growing focus on companion animal health, expansion of reference laboratories, technological advancements in immunodiagnostics.

The rising trend of pet adoption is expected to drive the growth of the veterinary infectious disease diagnostics market going forward. Pet adoption refers to the process of taking responsibility for a homeless or abandoned animal by providing it with a permanent home and care. Adoption rates are increasing as more individuals seek companionship, leading them to provide homes for homeless animals and improve their well-being. Veterinary infectious disease diagnostics support pet adoption by ensuring animals are healthy and free from contagious diseases, giving adopters confidence to bring pets home safely. For example, in 2023, according to Shelter Animals Count, a US-based non-governmental organization, dog adoptions increased by 109,000 compared with 2022, indicating positive growth in adoption rates, although total adoptions in 2023 remained nearly 108,000 lower than the prior year. Therefore, the growing rate of pet adoption is driving the veterinary infectious disease diagnostics market during the forecast period.

Leading companies operating in the veterinary diagnostics market are focusing on the development of advanced solutions, such as rapid molecular diagnostic kits, to replace traditional, time-consuming laboratory tests. A rapid molecular diagnostic kit is a tool that enables fast and accurate detection of infectious agents in animals, allowing veterinarians to make timely decisions while reducing laboratory workload. For instance, in June 2025, bioMérieux SA, a France-based diagnostics company, launched VETFIRE, a PCR kit for testing equine infectious respiratory diseases. This solution replaces conventional laboratory testing by providing rapid, sensitive, and multiplex detection of seven equine respiratory pathogens directly in veterinary practices. It delivers fast results, enabling veterinarians to accurately diagnose infections, monitor disease outbreaks, and implement treatment plans without delay. When integrated with bioMérieux’s diagnostic solutions, including antimicrobial resistance monitoring and laboratory support services, it offers a seamless diagnostic experience. The rapid molecular kit enhances diagnostic accuracy, simplifies veterinary operations, and improves animal health outcomes.

In April 2023, Mars Inc., a US-based provider of pet care products and veterinary diagnostic solutions, acquired Heska Corporation for an undisclosed amount. Through this acquisition, Mars aimed to expand its veterinary infectious disease diagnostics and point-of-care testing capabilities, broadening its comprehensive diagnostic offerings and accelerating research, development, and global market reach. Heska Corporation is a US-based provider of advanced veterinary diagnostic instruments, consumables, point-of-care infectious disease tests, informatics platforms, and specialty animal healthcare products.

Major companies operating in the veterinary infectious disease diagnostics market are Zoetis Inc., IDEXX Laboratories Inc., IDvet, NEOGEN Corporation, INDICAL BIOSCIENCE GmbH, Heska Corporation, Bio‑X Diagnostics, Virbac, Covetrus Inc., VCA Inc., Vetoquinol SA, BioChek B V, BioNote Inc, MEGACOR Diagnostik GmbH, AniCon Labor GmbH, AusDiagnostics Pty Ltd, Demedetic Diagnostics GmbH, Innovative Diagnostics, GD Animal Health, Biovet Inc, GeneReach, Biogal, Fassisi GmbH, Midland BioProducts, Vetsina Animal Diagnostics, Eurofins Technologies.

North America was the largest region in the veterinary disease diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary infectious disease diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the veterinary infectious disease diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have impacted the veterinary infectious disease diagnostics market by increasing the cost of imported diagnostic kits, reagents, and laboratory equipment, particularly affecting immunodiagnostics and molecular diagnostic segments in regions like north america and europe. While this has led to higher operational costs and slowed adoption, tariffs have also encouraged local manufacturing, R&D investments, and the development of cost-effective diagnostic solutions, benefiting domestic suppliers in the long term.

The veterinary infectious disease diagnostics market research report is one of a series of new reports that provides veterinary infectious disease diagnostics market statistics, including veterinary infectious disease diagnostics industry global market size, regional shares, competitors with a veterinary infectious disease diagnostics market share, detailed veterinary infectious disease diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary infectious disease diagnostics industry. This veterinary infectious disease diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Veterinary infectious disease diagnostics refer to diagnostic services used for the identification of infectious diseases in animals, encompassing infectious diseases and factors impacting the health of livestock, domestic animals, and wildlife. These diagnostics have become essential for ensuring the overall well-being of animals by diagnosing infections in various animal types.

The primary types of veterinary infectious disease diagnostics include viral infections, bacterial infections, parasitic infections, and other infections. Bacterial infections can be transmitted from dogs to humans through dog bites, while other infections caused by protozoa typically have a fecal-oral transmission route. Different animals, such as companion animals and food-producing animals, are covered by these diagnostics, utilizing various technologies like immunodiagnostics, molecular diagnostics, and other diagnostic methods. These diagnostic services are utilized across different settings, including reference laboratories, veterinary hospitals and clinics, point of care facilities, research institutes and universities, and other end-user environments.

The veterinary infectious disease diagnostics market includes revenues earned by entities by identifying and determining whether an animal has any viral, bacterial, parasitic, or other types of illnesses. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.